首页> 外文OA文献 >Evaluation of Multidrug Efflux Pump Inhibitors by a New Method Using Microfluidic Channels
【2h】

Evaluation of Multidrug Efflux Pump Inhibitors by a New Method Using Microfluidic Channels

机译:使用微流控通道的新方法评估多药外排泵抑制剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Fluorescein-di-β-d-galactopyranoside (FDG), a fluorogenic compound, is hydrolyzed by β-galactosidase in the cytoplasm of Escherichia coli to produce a fluorescent dye, fluorescein. We found that both FDG and fluorescein were substrates of efflux pumps, and have developed a new method to evaluate efflux-inhibitory activities in E. coli using FDG and a microfluidic channel device. We used E. coli MG1655 wild-type, ΔacrB (ΔB), ΔtolC (ΔC) and ΔacrBΔtolC (ΔBC) harboring plasmids carrying the mexAB-oprM (pABM) or mexXY-oprM (pXYM) genes of Pseudomonas aeruginosa. Two inhibitors, MexB-specific pyridopyrimidine (D13-9001) and non-specific Phe-Arg-β-naphthylamide (PAβN) were evaluated. The effects of inhibitors on pumps were observed using the microfluidic channel device under a fluorescence microscope. AcrAB-TolC and analogous pumps effectively prevented FDG influx in wild-type cells, resulting in no fluorescence. In contrast, ΔB or ΔC easily imported and hydrolyzed FDG to fluorescein, which was exported by residual pumps in ΔB. Consequently, fluorescent medium in ΔB and fluorescent cells of ΔC and ΔBC were observed in the microfluidic channels. D13-9001 substantially increased fluorescent cell number in ΔBC/pABM but not in ΔBC/pXYM. PAβN increased medium fluorescence in all strains, especially in the pump deletion mutants, and caused fluorescein accumulation to disappear in ΔC. The checkerboard method revealed that D13-9001 acts synergistically with aztreonam, ciprofloxacin, and erythromycin only against the MexAB-OprM producer (ΔBC/pABM), and PAβN acts synergistically, especially with erythromycin, in all strains including the pump deletion mutants. The results obtained from PAβN were similar to the results from membrane permeabilizer, polymyxin B or polymyxin B nonapeptide by concentration. The new method clarified that D13-9001 specifically inhibited MexAB-OprM in contrast to PAβN, which appeared to be a substrate of the pumps and permeabilized the membranes in E. coli.
机译:荧光素-二-β-d-吡喃半乳糖苷(FDG)是一种荧光化合物,在大肠杆菌的细胞质中被β-半乳糖苷酶水解,生成荧光染料荧光素。我们发现FDG和荧光素都是外排泵的底物,并且已经开发出一种新的方法来评估使用FDG和微流控通道设备在大肠杆菌中的外排抑制活性。我们使用大肠杆菌MG1655野生型,ΔacrB(ΔB),ΔtolC(ΔC)和ΔacrBΔtolC(ΔBC)携带携带铜绿假单胞菌mexAB-oprM(pABM)或mexXY-oprM(pXYM)基因的质粒。评价了两种抑制剂,MexB特异性吡啶并嘧啶(D13-9001)和非特异性Phe-Arg-β-萘酰胺(PAβN)。使用微流体通道装置在荧光显微镜下观察抑制剂对泵的作用。 AcrAB-TolC和类似的泵有效地防止了FDG流入野生型细胞,从而没有荧光。相反,ΔB或ΔC容易将FDG导入并水解为荧光素,而荧光素则由残留的泵以ΔB形式输出。因此,在微流体通道中观察到ΔB中的荧光介质以及ΔC和ΔBC的荧光细胞。 D13-9001大大增加了ΔBC/ pABM中的荧光细胞数量,但没有增加ΔBC/ pXYM中的荧光细胞数量。 PAβN在所有菌株中均增加了中等荧光,尤其是在泵缺失突变体中,并导致荧光素积累在ΔC中消失。棋盘法显示D13-9001仅对MexAB-OprM生产者(ΔBC/ pABM)与氨曲南,环丙沙星和红霉素具有协同作用,而PAβN在包括泵缺失突变体在内的所有菌株中均具有协同作用,尤其是与红霉素具有协同作用。从PAβN获得的结果在浓度上类似于从膜透化剂,多粘菌素B或多粘菌素B九肽获得的结果。新方法阐明,与PAβN相比,D13-9001特异性抑制了MexAB-OprM,PAβN似乎是泵的底物,并能在大肠杆菌中透化膜。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号